PTC Therapeutics, South Plainfield, NJ

PTC Therapeutics

www.ptcbio.com

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC`s ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

Number of Employees: 250-1000
Annual Revenue: $10-50 Million

www.ptcbio.com
100 Corporate Court
South Plainfield, NJ USA 07080
Phone: 908.222.7000

Name	Title	Contact Details
Pierre Gravier	Chief Financial Officer	Profile
Steve DeMarco	Director Pre-clinical R&D, Gene Therapy	Profile
Laurie Sokol	Senior Director R&D Finance	Profile
Ida Licata	Executive Director FP&A - R&D	Profile
Tom Hernandez	Sr. Director - R&D FP&A	Profile

Similar Companies

Freenome

Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent cancer. We have pioneered the most comprehensive multiomics platform for early cancer detection through a routine blood draw. By combining deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society`s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.

Kailos Genetics

Kailos Genetics, the maker of Praxis, provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions through identifying risks to common medications. Praxis is an easily accessible form of personalized medicine catered to your lifestyle.

HR Execs on the Move